in vitro News and Research

RSS

A combination of inhibitors may suppress tumor growth and prevent cancer relapse

An international team of researchers has demonstrated that a combination of inhibitors may suppress tumor growth and prevent relapse in patients with certain cancers, including head and neck squamous cell carcinoma and lung adenocarcinoma.

12 Sep 2023

New MRI technology promises to revolutionize understanding of iron homeostasis in the brain

Research team led by Shir Filo and Prof. Aviv Mezer of the Safra Center for Brain Science at the Hebrew University of Jerusalem (ELSC) and Dr. Tal Shahar currently, Director of the Neurosurgical Oncology Unit at the Neurosurgery Department, Tel Aviv Sourasky Medical Center, have unveiled a groundbreaking magnetic resonance imaging (MRI) technology that promises to revolutionize our understanding of iron homeostasis in the human brain.

12 Sep 2023

Chemotherapy drug may promote cancer growth by injuring surrounding cells

A standard chemotherapy drug injures surrounding non-cancer cells, which can then awakens dormant cancer cells and promotes cancer growth, according to a new study publishing September 12th in the open access journal PLOS Biology by Ramya Ganesan of Emory University, US, and colleagues.

12 Sep 2023

Human post-implantation embryo models show promise in unraveling early development

Researchers evaluate post-implantation development in humans using embryo-like models based on genetically unmodified human naïve embryonic stem cells.

12 Sep 2023

Exploring the anti-cancer potential of dark tea

The potential of dark tea in cancer prevention and management.

11 Sep 2023

Autobio's Autof MS Series has obtained the EU IVDR Class C registration certificate

Autobio’s Autof MS Series has obtained the EU IVDR Class C registration certificate.

From Autobio 11 Sep 2023

Unlocking the secrets of our body's first line of defense against strep throat and more

Researchers have mapped the complex structures of secretory immunoglobulin A (sIgA) in interaction with human CD89 and Streptococcus pyogenes M4, offering new insights into how our first line of mucosal defense operates. The study reveals the intricate ways these components may influence each other, impacting both bacterial survival strategies and host immune responses.

10 Sep 2023

Unlocking the secret drivers of deadly pancreatic cancer: New target offers hope for treatment

Researchers identify a super-enhancer-regulated RNA-binding protein cascade that drives the growth of pancreatic ductal adenocarcinoma, a deadly form of pancreatic cancer. The discovery offers a promising new avenue for targeted therapy, potentially sidestepping severe side effects associated with other treatments.

10 Sep 2023

3D bioprinting methods for fabricating bioengineered blood vessel models

A review paper by scientists at the Chonnam National University summarized the recent research on bioprinting methods for fabricating bioengineered blood vessel models.

8 Sep 2023

Are airborne microplastics damaging your lungs? New study probes potential risks

Researchers review the presence and impact of airborne microplastics (AMPs) on human respiratory health in a new study published in the Science of the Total Environment. The study underscores the urgent need for more data on the toxicity of AMPs, which are prevalent in indoor environments and could pose serious health risks, especially to vulnerable populations like children and older adults.

7 Sep 2023

Chronic inflammation's influence on TP53 mutations in leukemia evolution explored in new study

Researchers performed a multi-omics evaluation of HSPCs obtained from individuals with myeloproliferative neoplasms transforming to TP53-related secondary forms of acute myeloid leukemia.

7 Sep 2023

Newly discovered nanobody may lead to a treatment for Retinitis Pigmentosa

A team of scientists from the University of California, Irvine, believe they have discovered a special antibody which may lead to a treatment for Retinitis Pigmentosa, a condition that causes loss of central vision, as well as night and color vision.

7 Sep 2023

RIT researchers use CRISPR to develop new treatment for degenerative disc disease

Rochester Institute of Technology researchers are improving non-invasive treatment options for degenerative disc disease, an ailment that impacts 3 million adults yearly in the U.S., according to the Mayo Clinic.

6 Sep 2023

CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems

Partnership to provide customers with direct access to portfolio of highly characterized hepatic cells to recreate advanced Liver-on-a-Chip assays.

From CN Bio 6 Sep 2023

SARS-CoV-2 spike protein could be speeding up Alzheimer's and other brain diseases, says new study

Swedish researchers find that SARS-CoV-2's spike protein amyloids can accelerate the formation of harmful protein aggregates related to neurodegenerative diseases like Creutzfeldt-Jakob and Alzheimer's. The study suggests a potential link between COVID-19 and increased cases of these brain disorders.

5 Sep 2023

How SARS-CoV-2 hijacks Fragile X proteins to fuel infection: New clues in COVID-19 and genetic disorders

Study explores the interaction between SARS-CoV-2's non-structural protein 3 (NSP3) and proteins related to Fragile X mental retardation (FMRPs), shedding light on COVID-19 pathophysiology. The research suggests that the virus exploits these host cell proteins for effective infection and possibly interferes with antiviral defense mechanisms, offering new insights into the genetic basis of Fragile X syndrome.

5 Sep 2023

SARS-CoV-2 Eris variant spreads faster and dodges immunity

Study investigates the characteristics of the EG.5.1 "Eris" variant of SARS-CoV-2, finding it more transmissible among hamsters and slightly better at evading immunity compared to the XBB.1.5 variant. The results suggest that these properties could be driving the variant's increasing prevalence in human populations.

5 Sep 2023

Study characterizes SARS-CoV-2 subvariants to inform development of next-generation COVID-19 vaccines

Researchers characterized two novel SARS-CoV-2 XBB variants, EG.5.1 and XBB.2.3.

4 Sep 2023

New biomarker could help identify people at risk for vascular dementia

Dementia is a group of brain diseases that share similar symptoms, such as memory, language, orientation, and behavioral issues. Vascular dementia generally develops in the elderly, affecting between 1% and 4% of people over the age of 65, according to Alzheimer's Switzerland.

4 Sep 2023

Mycotoxin contamination is still a serious food/feed safety issue

The updated and most recent evidence of the occurrence and co-occurrence of mycotoxins.

4 Sep 2023

in vitro News and Research

A combination of inhibitors may suppress tumor growth and prevent cancer relapse

New MRI technology promises to revolutionize understanding of iron homeostasis in the brain

Chemotherapy drug may promote cancer growth by injuring surrounding cells

Human post-implantation embryo models show promise in unraveling early development

Exploring the anti-cancer potential of dark tea

Autobio's Autof MS Series has obtained the EU IVDR Class C registration certificate

Unlocking the secrets of our body's first line of defense against strep throat and more

Unlocking the secret drivers of deadly pancreatic cancer: New target offers hope for treatment

3D bioprinting methods for fabricating bioengineered blood vessel models

Are airborne microplastics damaging your lungs? New study probes potential risks

Chronic inflammation's influence on TP53 mutations in leukemia evolution explored in new study

Newly discovered nanobody may lead to a treatment for Retinitis Pigmentosa

RIT researchers use CRISPR to develop new treatment for degenerative disc disease

CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems

SARS-CoV-2 spike protein could be speeding up Alzheimer's and other brain diseases, says new study

How SARS-CoV-2 hijacks Fragile X proteins to fuel infection: New clues in COVID-19 and genetic disorders

SARS-CoV-2 Eris variant spreads faster and dodges immunity

Study characterizes SARS-CoV-2 subvariants to inform development of next-generation COVID-19 vaccines

New biomarker could help identify people at risk for vascular dementia

Mycotoxin contamination is still a serious food/feed safety issue

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News